Clinical Trial Update: Hypertension in Hemodialysis Patients (Aim 3) [Phase 3]

View source ↗

Summary

A Phase 3 trial for hypertension in patients receiving hemodialysis was terminated, and its results were posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension
• Left Ventricular Hypertrophy

Snippet

Sponsor: Indiana University | Conditions: Hemodialysis, Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2016-01-18